Morgan Stanley’s Defiance Daily Target 2X Long AVGO ETF AVGX Stock Holding History

Morgan Stanley’s Portfolio AVGX Stock Details AVGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,742	Closed	-$381K	–	8254
2024 Q4	$381K	Buy	+11,742	New	+$268K	﹤0.01%	5536

Other funds holding AVGX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's AVGX Position: Q1 2025 in Review

Morgan Stanley sold out of Defiance Daily Target 2X Long AVGO ETF (AVGX) in Q1 2025, closing a stake of 11,742 shares — an estimated $381K sold.

Morgan Stanley first reported a position in AVGX in Q4 2024 and held it in 1 quarter. The position peaked at $381K in Q4 2024. 7 funds tracked by Wall St. Rank hold AVGX as of Q1 2025.

Morgan Stanley reported no remaining Defiance Daily Target 2X Long AVGO ETF position as of Q1 2025 after selling out during the quarter.
Morgan Stanley sold 11,742 Defiance Daily Target 2X Long AVGO ETF shares in Q1 2025, an estimated $381K.
Morgan Stanley first reported a position in Defiance Daily Target 2X Long AVGO ETF in Q4 2024 and held it in 1 quarter.
Morgan Stanley's Defiance Daily Target 2X Long AVGO ETF position peaked at $381K in Q4 2024.
7 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long AVGO ETF as of Q1 2025.

Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.